Carmignac Patrimoine: Letter from the Fund Manager

  • -5.15%
    Carmignac Patrimoine’s performance

    in the 2nd quarter of 2022 for the A EUR Share class

  • -5.32%
    Reference indicator’s performance

    in the 2nd quarter of 2022 for 40% MSCI ACWI (USD) (Reinvested net dividends) + 40% ICE BofA Global Government Index (USD) + 20% ESTER capitalised. Quarterly rebalanced

  • -12.22%
    Performance of the Fund Year to date

    versus -8.28% for the reference indicator

In the second quarter of 2022, Carmignac Patrimoine recorded a performance of -5.15%, in line with its reference indicator1 (-5.32%).

Market environment

Inflation has shown no sign of abating over the quarter, driven by high commodity prices, ongoing supply disruptions, as well as both a tight job and a hot housing market in the US. As a result, Central banks in developed markets pursued increasingly hawkish monetary policies, with the Federal reserve increasing its key interest rate by 75 bp to a range between 1.5 and 1.75%, and the ECB preparing markets for a July hike, a direction not taken since 2011. Towards the end of the period, growth showed first signs of weakness, illustrated by low PMI readings, shifting market’s focus towards the economic slowdown. Higher rates weighed on risky assets, leading to lower equity valuations (ex-energy) as well as credit spreads’ widening. Recession fears in June provided some relief on rates, allowing markets to catch their breath. In China, the resurgence of Covid cases at the beginning of the period led to strict lockdowns, stalling further its economy, and weighing on the performance of the region. Towards the end of the period, an improvement of the health situation coupled with hopes of stimulus and an easing of regulatory measures fuelled a rebound of the region.

How did we fare in this context?

Carmignac Patrimoine recorded a negative performance over the period. Our contributors to performance can be summarized as followed:

  • Positive contribution of our equity and credit hedges, as well as defensive stock selection within healthcare
  • Negative contribution of our overall equity and credit book, our positions on longer maturity US bonds (reflecting lower future growth) as well as our protections on peripheral debt (on the back of increased fragmentation risks)

Our approach entering this quarter was one of caution. Indeed, we expected the Federal reserve to tighten “whatever it took”- regardless of the impacts on financial assets. Meanwhile, we expected the ECB to find itself in a very tough spot, having to address inflation in a much dire growth and much more indebted environment. We thus maintained a very defensive approach, characterized by a low equity exposure (13% on average over the period), reduced credit investments coupled with increased CDS protections. This positioning was very efficient in compensating for the broad equity losses. However, it was insufficient to mitigate the widening of credit spreads, who suffered the double blow of both higher interest rate and credit risk.

On the equity side, our rebalancing towards more defensive stocks proved rewarding, as illustrated by the positive performance of our healthcare names (Eli Lilly, Novo Nordisk). However, our gold allocation, increased over the period in order to manage geopolitical and economic risks, failed to act as a safe haven. On the fixed income side, we were positioned for a flattening of the US yield curve, as we anticipated higher short-term rates on the back of policy normalization to start weighing on growth, reflected in longer maturities. While the curve did flatten, longer term maturities ended up higher as well, resulting in a parallel shift of the yield curve. Finally, a tighter ECB monetary policy reignited fragmentation risks: countries like Italy that were able to borrow at low rates were seen as vulnerable to higher “normalized” interest rates, given their debt to GDP ratio has skyrocketed in recent years. We had consequently initiated short positions on Italian debt to protect against such risk, which didn’t materialize as the Central bank managed to reassure markets towards the end of the period.

What is our outlook for the coming months?

Central banks are not showing any sign yet that they are moving away from aggressive tightening. In fact, Jerome Powell has reiterated in front of congress that he’d be reluctant to lower interest rates until there is clear evidence that inflation is receding. The Bank of International Settlement also warned that “Central banks should raise rates sharply or risk high-inflation era”. In Europe, addressing the fragmentation risks signals the ECB’s intentions to follow a strict tightening path, in the wake of the Federal reserve. However, inflation will have to be delt with all the while growth increasingly weakens, dragged by a lasting war in Ukraine, as well as ongoing and prospective sanctions. Central banks are thus stuck between a rock and a hard place, and the key question for us is not whether they can tackle inflation without leading developed economies into a recession, but rather how hard the landing will be. In China, the government’s supportive policy mix, likely to step up as the health situation improves, puts the country in an appreciably different and much better position than its western peers.

On the equity side, after market valuations suffered from rising rates in the first half of the year, corporate earnings should be the driving force of equity markets going forward. However, while earnings have shown resilience since the beginning of the year, they should globally come under pressure as the impact of higher costs and companies’ capacity to pass it onto consumers are yet to be reflected in their margins. As a result, our focus on quality companies, characterized by high and stable margins and/or solid growth prospects, should support performance going forward, especially since most of them have considerably derated since the beginning of the year. We favor defensive sectors with quality attributes, notably within healthcare, consumer staples and software, that have gained momentum as markets shift their focus to slowing growth. We balance out this core positioning with an overweight in the energy sector. Despite the sector being cyclical, our view is that demand recovery and tightness in supply should lead to a multiyear cycle of capital spending by oil companies. Besides, oil and gas continue to satisfy a substantial portion of energy demand, while renewables continue to grow, displacing coal. Certain traditional energy companies operating in this transition are thus particularly well positioned in the current environment. Finally, we have stepped up our Chinese exposure, which we’re now overweight vs reference indicator, as we see momentum building there on the back of more favorable policy and regulatory mix, magnified by the massive derating of the past months.

On the fixed income side, our view is that credit markets have to a great extent integrated both tighter monetary policies and recession risks, as illustrated by the extreme and historical spike in volatility since the beginning of the year. Underneath the surface, this has provided various specific opportunities which we are steadily gaining exposure to, while still covering the overall market risk. In fact, we find the yield on some of those securities largely compensate for the current volatility. Within credit, we notably favor subordinated financial debt, as European banks’ recapitalization has made them more resilient, while higher yields have improved their profitability. We also favor CLOs (collateralized loan obligation), due to their floating rate structure backed by investment grade loans (BBB) that offer an interesting carry. On the sovereign front, we stay cautious on Eurozone bonds given the ECB’s willingness to proceed with its monetary tightening. We currently hold short positions on Italian and German debt. Within Emerging markets, we like countries that benefit from onshoring/reshoring dynamics (the practice of bringing back manufacturing closer to one’s country), commodity exporting as well as positive real yields. For example, at current levels, we find Mexican bonds attractive, especially since the oil-exporting country is well positioned to take over part of Chinese export of goods to the US.

Overall, the end of accommodative policies means the return of volatility. We believe it calls for a flexible asset allocation, as well as an active management of risks. In this regard, we maintain our cautious approach going into the third quarter, characterized by a low equity exposure (around 17%), a high cash allocation (29%) that we stand ready to deploy as markets continue to dislocate, as well as an exposure to safe-haven assets like the US dollar (40%) and gold (3%), the latter tending to perform well in unstable geopolitical and inflationary environments. Underneath this cautiousness, we are preparing Carmignac Patrimoine for the market recovery that will eventually take place, effectively sowing the seeds of future major performance drivers.

1Reference indicator: 40% MSCI ACWI (USD) (Reinvested net dividends) + 40% ICE BofA Global Government Index (USD) + 20% ESTER capitalised. Quarterly rebalanced. Until 31 December 2012, the reference indicators' equity indices were calculated ex-dividend. Since 1 January 2013, they have been calculated with net dividends reinvested. Until 31 December 2020, the bond index was the FTSE Citigroup WGBI All Maturities Eur. Until 31 December 2021, the Fund's reference indicator comprised 50% MSCI AC World NR (USD) (net dividends reinvested), and 50% ICE BofA Global Government Index (USD) (coupons reinvested). Performances are presented using the chaining method. From 01/ 01/ 2013 the equity index reference indicators are calculated net dividends reinvested. Past performance is not necessarily indicative of future performance. The return may increase or decrease as a result of currency fluctuations. Performances are net of fees (excluding possible entrance fees charged by the distributor).

Carmignac Patrimoine

Looking for best asset allocation in all market conditions

Discover the fund page

Carmignac Patrimoine A EUR Acc

ISIN: FR0010135103

Recommended minimum investment horizon

Lower risk Higher risk

1 2 3 4 5 6 7
Main risks of the Fund

EQUITY: The Fund may be affected by stock price variations, the scale of which is dependent on external factors, stock trading volumes or market capitalization.

INTEREST RATE: Interest rate risk results in a decline in the net asset value in the event of changes in interest rates.

CREDIT: Credit risk is the risk that the issuer may default.

CURRENCY: Currency risk is linked to exposure to a currency other than the Fund’s valuation currency, either through direct investment or the use of forward financial instruments.

The Fund presents a risk of loss of capital.

Carmignac Patrimoine A EUR Acc

ISIN: FR0010135103
2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 (YTD)
Year to date
Carmignac Patrimoine A EUR Acc +8.81 % +0.72 % +3.88 % +0.09 % -11.29 % +10.55 % +12.40 % -0.88 % -9.38 % +2.20 % +4.86 %
Reference Indicator +15.97 % +8.35 % +8.05 % +1.47 % -0.07 % +18.18 % +5.18 % +13.34 % -10.26 % +7.73 % +3.27 %

Scroll right to see full table

3 Years 5 Years 10 Years
Carmignac Patrimoine A EUR Acc -2.01 % +2.82 % +1.82 %
Reference Indicator +3.05 % +5.25 % +6.28 %

Scroll right to see full table

Source: Carmignac at 31/05/2024

Entry costs : 4,00% of the amount you pay in when entering this investment. This is the most you will be charged. Carmignac Gestion doesn't charge any entry fee. The person selling you the product will inform you of the actual charge.
Exit costs : We do not charge an exit fee for this product.
Management fees and other administrative or operating costs : 1,51% of the value of your investment per year. This estimate is based on actual costs over the past year.
Performance fees : 20,00% max. of the outperformance once performance since the start of the year exceeds that of the reference indicator and if no past underperformance still needs to be offset. The actual amount will vary depending on how well your investment performs. The aggregated cost estimation above includes the average over the last 5 years, or since the product creation if it is less than 5 years.
Transaction Cost : 0,63% of the value of your investment per year. This is an estimate of the costs incurred when we buy and sell the investments underlying the product. The actual amount varies depending on the quantity we buy and sell.

Marketing communication. Please refer to the KID/KIID, prospectus of the fund before making any final investment decisions. This document is intended for professional clients.

This material may not be reproduced, in whole or in part, without prior authorisation from the Management Company. This material does not constitute a subscription offer, nor does it constitute investment advice. This material is not intended to provide, and should not be relied on for, accounting, legal or tax advice. This material has been provided to you for informational purposes only and may not be relied upon by you in evaluating the merits of investing in any securities or interests referred to herein or for any other purposes. The information contained in this material may be partial information and may be modified without prior notice. They are expressed as of the date of writing and are derived from proprietary and non-proprietary sources deemed by Carmignac to be reliable, are not necessarily all-inclusive and are not guaranteed as to accuracy. As such, no warranty of accuracy or reliability is given and no responsibility arising in any other way for errors and omissions (including responsibility to any person by reason of negligence) is accepted by Carmignac, its officers, employees or agents.

Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor). The return may increase or decrease as a result of currency fluctuations, for the shares which are not currency-hedged.

Reference to certain securities and financial instruments is for illustrative purposes to highlight stocks that are or have been included in the portfolios of funds in the Carmignac range. This is not intended to promote direct investment in those instruments, nor does it constitute investment advice. The Management Company is not subject to prohibition on trading in these instruments prior to issuing any communication. The portfolios of Carmignac funds may change without previous notice. The reference to a ranking or prize, is no guarantee of the future results of the UCIS or the manager.

Morningstar Rating™ : © Morningstar, Inc. All Rights Reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

Access to the Funds may be subject to restrictions regarding certain persons or countries. This material is not directed to any person in any jurisdiction where (by reason of that person’s nationality, residence or otherwise) the material or availability of this material is prohibited. Persons in respect of whom such prohibitions apply must not access this material. Taxation depends on the situation of the individual. The Funds are not registered for retail distribution in Asia, in Japan, in North America, nor are they registered in South America. Carmignac Funds are registered in Singapore as restricted foreign scheme (for professional clients only). The Funds have not been registered under the US Securities Act of 1933. The Funds may not be offered or sold, directly or indirectly, for the benefit or on behalf of a «U.S. person», according to the definition of the US Regulation S and FATCA. The risks, fees and ongoing charges are described in the KID (Key Information Document). The KID must be made available to the subscriber prior to subscription. The subscriber must read the KID. Investors may lose some or all their capital, as the capital in the funds are not guaranteed. The Funds present a risk of loss of capital.

The Funds’ prospectus, KIDs, NAVs and annual reports are available at, or upon request to the Management Carmignac Portfolio refers to the sub-funds of Carmignac Portfolio SICAV, an investment company under Luxembourg law, conforming to the UCITS Directive. The French investment funds (fonds communs de placement or FCP) are common funds in contractual form conforming to the UCITS or AIFM Directive under French law.

  • In France, Luxembourg, Sweden: The risks, fees and ongoing charges are described in the KID (Key Information Document). The KID must be made available to the subscriber prior to subscription. The subscriber must read the KID. Investors may lose some or all their capital, as the capital in the funds are not guaranteed. The Funds present a risk of loss of capital. The Funds’ prospectus, KIDs, NAV and annual reports are available at, or upon request to the Management.

  • In the United Kingdom: the Funds’ respective prospectuses, KIIDs and annual reports are available at, or upon request to the Management Company, or for the French Funds, at the offices of the Facilities Agent at BNP PARIBAS SECURITIES SERVICES, operating through its branch in London: 55 Moorgate, London EC2R. This document was prepared by Carmignac Gestion, Carmignac Gestion Luxembourg or Carmignac UK Ltd. FP Carmignac ICVC (the “Company”) is an Investment Company with variable capital incorporated in England and Wales under registered number 839620 and is authorised by the FCA with effect from 4 April 2019 and launched on 15 May 2019. FundRock Partners Limited is the Authorised Corporate Director (the “ACD”) of the Company and is authorised and regulated by the FCA. Registered Office: Hamilton Centre, Rodney Way, Chelmsford, Essex, CM1 3BY, UK; Registered in England and Wales with number 4162989. Carmignac Gestion Luxembourg SA has been appointed as the Investment Manager and distributor in respect of the Company. Carmignac UK Ltd (Registered in England and Wales with number 14162894) has been appointed as a sub-Investment Manager of the Company and is authorised and regulated by the Financial Conduct Authority with FRN:984288.

  • In Switzerland: the prospectus, KIDs and annual report are available at, or through our representative in Switzerland, CACEIS (Switzerland), S.A., Route de Signy 35, CH-1260 Nyon. The paying agent is CACEIS Bank, Montrouge, Nyon Branch / Switzerland, Route de Signy 35, 1260 Nyon.

The Management Company can cease promotion in your country anytime. Investors have access to a summary of their rights in English on the following links: UK ; Switzerland ; France ; Luxembourg ; Sweden.